| Biopython: freely available Python tools for computational molecular biology and bioinformatics PJA Cock, T Antao, JT Chang, BA Chapman, CJ Cox, A Dalke, I Friedberg, ... Bioinformatics 25 (11), 1422, 2009 | 5395 | 2009 |
| Oncogenic pathway signatures in human cancers as a guide to targeted therapies AH Bild, G Yao, JT Chang, Q Wang, A Potti, D Chasse, MB Joshi, ... Nature 439 (7074), 353-357, 2006 | 2359 | 2006 |
| High tumor mutation burden fails to predict immune checkpoint blockade response across all cancer types DJ McGrail, PG Pilié, NU Rashid, L Voorwerk, M Slagter, M Kok, ... Annals of Oncology 32 (5), 661-672, 2021 | 802 | 2021 |
| High-dimensional sparse factor modeling: Applications in gene expression genomics CM Carvalho, J Chang, JE Lucas, JR Nevins, Q Wang, M West Journal of the American Statistical Association 103 (484), 1438-1456, 2008 | 667 | 2008 |
| Integrating genotype and phenotype information: an overview of the PharmGKB project TE Klein, JT Chang, MK Cho, KL Easton, R Fergerson, M Hewett, Z Lin, ... The pharmacogenomics journal 1 (3), 167-170, 2001 | 514 | 2001 |
| Anchorage-independent cell growth signature identifies tumors with metastatic potential S Mori, JT Chang, ER Andrechek, N Matsumura, T Baba, G Yao, JW Kim, ... Oncogene 28 (31), 2796-2805, 2009 | 402 | 2009 |
| GATHER: a systems approach to interpreting genomic signatures JT Chang, JR Nevins Bioinformatics 22 (23), 2926-2933, 2006 | 399 | 2006 |
| FOXC2 expression links epithelial–mesenchymal transition and stem cell properties in breast cancer BG Hollier, AA Tinnirello, SJ Werden, KW Evans, JH Taube, TR Sarkar, ... Cancer research 73 (6), 1981-1992, 2013 | 326 | 2013 |
| Creating an online dictionary of abbreviations from MEDLINE JT Chang, H Schütze, RB Altman Journal of the American Medical Informatics Association 9 (6), 612-620, 2002 | 306 | 2002 |
| Associating genes with gene ontology codes using a maximum entropy analysis of biomedical literature S Raychaudhuri, JT Chang, PD Sutphin, RB Altman Genome Research 12 (1), 203-214, 2002 | 278 | 2002 |
| Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state GV Echeverria, Z Ge, S Seth, X Zhang, S Jeter-Jones, X Zhou, S Cai, Y Tu, ... Science translational medicine 11 (488), eaav0936, 2019 | 257 | 2019 |
| Biopython: Python tools for computational biology B Chapman, J Chang ACM Sigbio Newsletter 20 (2), 15-19, 2000 | 245 | 2000 |
| Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer TZ Tan, QH Miow, RYJ Huang, MK Wong, J Ye, JA Lau, MC Wu, ... EMBO molecular medicine 5 (7), 1051-1066, 2013 | 232 | 2013 |
| Basic microarray analysis: grouping and feature reduction S Raychaudhuri, PD Sutphin, JT Chang, RB Altman TRENDS in Biotechnology 19 (5), 189-193, 2001 | 211 | 2001 |
| Amplification and high-level expression of heat shock protein 90 marks aggressive phenotypes of human epidermal growth factor receptor 2 negative breast cancer Q Cheng, JT Chang, J Geradts, LM Neckers, T Haystead, NL Spector, ... Breast cancer research 14, 1-15, 2012 | 201 | 2012 |
| A dynamic bronchial airway gene expression signature of chronic obstructive pulmonary disease and lung function impairment K Steiling, M Van Den Berge, K Hijazi, R Florido, J Campbell, G Liu, ... American journal of respiratory and critical care medicine 187 (9), 933-942, 2013 | 187 | 2013 |
| Dissecting the heterogeneity of skin gene expression patterns in systemic sclerosis S Assassi, WR Swindell, M Wu, FD Tan, D Khanna, DE Furst, DP Tashkin, ... Arthritis & rheumatology 67 (11), 3016-3026, 2015 | 166 | 2015 |
| Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease H Amano, A Chaudhury, C Rodriguez-Aguayo, L Lu, V Akhanov, A Catic, ... Cell metabolism 29 (6), 1274-1290. e9, 2019 | 156 | 2019 |
| EMTome: a resource for pan-cancer analysis of epithelial-mesenchymal transition genes and signatures SV Vasaikar, AP Deshmukh, P den Hollander, S Addanki, NA Kuburich, ... British journal of cancer 124 (1), 259-269, 2021 | 152 | 2021 |
| Candidate antimetastasis drugs suppress the metastatic capacity of breast cancer cells by reducing membrane fluidity W Zhao, S Prijic, BC Urban, MJ Tisza, Y Zuo, L Li, Z Tan, X Chen, SA Mani, ... Cancer research 76 (7), 2037-2049, 2016 | 152 | 2016 |
